United States · FDA National Drug Code directory
Orapred ODT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59212-701_d172c0d5-b118-4433-92bd-05214976dd8f
- Product NDC
- 59212-701
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- prednisolone sodium phosphate
- Labeler
- Advanz Pharma (US) Corp.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20060601
- Source listing expiry
- 20261231
Source-listed ingredients
- PREDNISOLONE SODIUM PHOSPHATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (59212-701-12) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (59212-701-06) · 59212-701-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →